National Heart, Lung, and Blood Institute (NHLBI)

NHLBI may award administrative supplements under rare circumstances and contingent upon the availability of funds; consideration will be given for the following:

Research Project Grants (RPG):

• Preservation of a unique research material or resource that may otherwise be lost
• Provision for an orderly termination or temporary continuation of support
• Replacement of equipment, supplies, and/or time lost

Career Related:

• Full or part-time mentored research training experiences to Reenter, Reintegrate, or Retrain (RRR) in an active research career
• Research continuity and retention of investigators facing critical life events who are either transitioning from mentored career development awards to research independence or are first-time RPG awardees preparing for a renewal of their current award or a second NIH RPG award, with the goal to minimize departures from biomedical research workforce.

Research Project Grants (RPG) - 60 days before requested start date 

Career Related 

• RRR - 90 days before requested start date (awards not issued October and November)
• Research Continuity and Retention - February 1, June 1, and October 1

RPG:

Contact the Program Officer listed on the Notice of Award for the most recent parent award and/or the NHLBI Office of Grants Management [email protected] 

Career Related:

Research Re-entry, Re-integrate, or Re-train

[email protected]

Research Continuity and Retention

[email protected]

The NHLBI supports conferences that are critical to the mission of the NIH and NHLBI (i.e., meetings directly related to heart, lung, non-plastic blood, and/or sleep disorders and conditions), including advancing the science of solution-focused health disparities research, implementation science, community-engaged research, and global health reciprocal innovation or any combination of these. Meetings for the sole purpose of professional development (e.g., continuing medical education) fall outside of NHLBI priorities. Supported meetings generally explore and identify: (a) critical gaps in knowledge; (b) research challenges and opportunities; and/or (c) promising strategies for advancing prevention, diagnosis and/or treatment modalities for science related to the NHLBI mission.

The NHLBI accepts primary and secondary assignments on applications for the support of meetings directly related to heart, lung, blood, and sleep disorders and conditions. Typically, NHLBI provides nominal support for conferences between $5K and $10K.

Applicants should select a submission date that allows sufficient time for NHLBI to make a potential award prior to the conference/meeting event.

NHLBI will consider support requests for a series of annual or biannual conferences for up to 5 years.

Scientific Program Contact:  
NHLBI Conferences and Meetings
Email: [email protected]

Grants Management Contact:
NHLBI Office of Grants Management
Email: [email protected]

The National Heart Lung and Blood Institute (NHLBI) is interested in supporting the development of novel therapeutics, devices, diagnostics, digital health technologies, research tools, and other innovative solutions for advancing the prevention, diagnosis, and treatment of heart, lung, blood, and sleep (HLBS) diseases and disorders. 

Topics of particular interest for the NHLBI SBIR/STTR program include, but are not limited to, the following topics: 

• Technologies addressing HLBS complications relevant to maternal health and women’s health  
• Artificial Intelligence/Machine Learning technologies to improve the diagnosis, treatment, and prevention of HLBS diseases and disorders 
• Precision medicine approaches to treating HLBS diseases and disorders 
• New approach methodologies, tools, and point-of-care technologies to improve detection and therapeutic development for HLBS diseases and disorders 

• NHLBI accepts Phase IIB SBIR projects
• NHLBI accepts Commercialization Readiness Pilot (CRP) projects

• NHLBI accepts clinical trials through the SBIR programs
• NHLBI accepts clinical trials through the STTR programs
• NHLBI accepts clinical trials through the Phase IIB SBIR program

[email protected]